Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
25283 | 237 | 31.9 | 58% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1388 | 7661 | CONGENITAL HEART BLOCK//NEONATAL LUPUS//NEONATAL LUPUS ERYTHEMATOSUS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ROS DNA | Author keyword | 6 | 100% | 2% | 4 |
2 | ROS HSA | Author keyword | 3 | 100% | 1% | 3 |
3 | JN MED | Address | 3 | 10% | 11% | 26 |
4 | ONOO MTDNA | Author keyword | 1 | 100% | 1% | 2 |
5 | PEROXYNITRITE MODIFIED DNA | Author keyword | 1 | 100% | 1% | 2 |
6 | ROS IGG | Author keyword | 1 | 100% | 1% | 2 |
7 | ANTI DNA AUTOANTIBODIES | Author keyword | 1 | 20% | 2% | 4 |
8 | PHOTOADDUCT | Author keyword | 1 | 23% | 1% | 3 |
9 | ANTI NDNA ANTIBODIES | Author keyword | 1 | 50% | 0% | 1 |
10 | B CONFORMATION | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ROS DNA | 6 | 100% | 2% | 4 | Search ROS+DNA | Search ROS+DNA |
2 | ROS HSA | 3 | 100% | 1% | 3 | Search ROS+HSA | Search ROS+HSA |
3 | ONOO MTDNA | 1 | 100% | 1% | 2 | Search ONOO++MTDNA | Search ONOO++MTDNA |
4 | PEROXYNITRITE MODIFIED DNA | 1 | 100% | 1% | 2 | Search PEROXYNITRITE+MODIFIED+DNA | Search PEROXYNITRITE+MODIFIED+DNA |
5 | ROS IGG | 1 | 100% | 1% | 2 | Search ROS+IGG | Search ROS+IGG |
6 | ANTI DNA AUTOANTIBODIES | 1 | 20% | 2% | 4 | Search ANTI+DNA+AUTOANTIBODIES | Search ANTI+DNA+AUTOANTIBODIES |
7 | PHOTOADDUCT | 1 | 23% | 1% | 3 | Search PHOTOADDUCT | Search PHOTOADDUCT |
8 | ANTI NDNA ANTIBODIES | 1 | 50% | 0% | 1 | Search ANTI+NDNA+ANTIBODIES | Search ANTI+NDNA+ANTIBODIES |
9 | B CONFORMATION | 1 | 50% | 0% | 1 | Search B+CONFORMATION | Search B+CONFORMATION |
10 | CANCER AUTOANTIBODIES | 1 | 50% | 0% | 1 | Search CANCER+AUTOANTIBODIES | Search CANCER+AUTOANTIBODIES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VARYING SIZE | 11 | 50% | 7% | 16 |
2 | RECOGNIZE UNIQUE CONFORMATION | 8 | 100% | 2% | 5 |
3 | ANTIGEN BINDING CHARACTERISTICS | 6 | 71% | 2% | 5 |
4 | NATIVE DNA | 3 | 14% | 9% | 21 |
5 | SPECIES MODIFIED DNA | 2 | 50% | 1% | 3 |
6 | MODIFIED AUTOANTIGENS | 1 | 33% | 1% | 2 |
7 | TRICHLOROETHENE MEDIATED AUTOIMMUNITY | 1 | 50% | 0% | 1 |
8 | CHEMICAL DETERMINATION | 1 | 18% | 1% | 3 |
9 | RADICAL MODIFIED DNA | 0 | 33% | 0% | 1 |
10 | REACTIVE AUTOANTIBODIES | 0 | 17% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Oxygen free radicals and systemic autoimmunity | 2003 | 90 | 85 | 25% |
Interaction between glutathione and apoptosis in systemic lupus erythematosus | 2013 | 9 | 102 | 11% |
Macrophages and neutrophils in SLE-An online molecular catalog | 2012 | 12 | 91 | 9% |
Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases | 2014 | 6 | 95 | 6% |
Oxidatively modified autoantigens in autoimmune diseases | 2006 | 65 | 87 | 7% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JN MED | 3 | 10% | 11% | 26 |
2 | CHAIR PROPAEDEUT INTERNAL DIS | 1 | 50% | 0.4% | 1 |
3 | FOOD BEVERAGE SAFETY | 1 | 50% | 0.4% | 1 |
4 | GRP RECH BIOTECHNOL PATHOL | 1 | 50% | 0.4% | 1 |
5 | ICMR AGING BRAIN CRAB | 1 | 50% | 0.4% | 1 |
6 | ARTHRIT RHEUMAT DIS OP09 | 0 | 20% | 0.8% | 2 |
7 | CHAIR SKIN VENEREAL DIS | 0 | 33% | 0.4% | 1 |
8 | HOP HABIB BOURGUIBA | 0 | 33% | 0.4% | 1 |
9 | INTERNAL MED RHEUMATOL MED | 0 | 33% | 0.4% | 1 |
10 | UNIT BIOTECHNOL PATHOL | 0 | 33% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000197336 | ANTI DNA//ANTI DNA ANTIBODIES//ANTI DSDNA ANTIBODIES |
2 | 0.0000130149 | 8 HYDROXY 2 DEOXYGUANOSINE//8 OXOGUO//8 OXO 2 DEOXYGUANOSINE |
3 | 0.0000118348 | CARRAGEENAN INDUCED GRANULOMA//COPPER ACETYLSALICYLATE//CHRONIC INFLAMMATORY JOINT DISEASE |
4 | 0.0000091536 | ZENTRUM PHARMAKOL//URINARY NITRITE NITRATE//AIDS PATHOGENESIS MOL THER EUT |
5 | 0.0000088426 | MERCAPTALBUMIN//BROMCRESOL PURPLE//CYSTEINE 34 |
6 | 0.0000084152 | CADION//PHARMACEUT SCI 51 OHE HONMACHI//RECTIFIED CONCENTRATED MUST |
7 | 0.0000083681 | COSALANE//AURINTRICARBOXYLIC ACID//AURINTRICARBOXYLIC ACID ATA |
8 | 0.0000076213 | MIXED CONNECTIVE TISSUE DISEASE//LA SS B//RO SS A |
9 | 0.0000072145 | MAGNETIC RELAXATION SWITCH//DYSAUTONOMIA FAMILIAL//MAGNETIC IRON OXIDE NANOPARTICLES MION |
10 | 0.0000069621 | DITHIONITROBENZOATE//IGG BLOOD//YOSHIDA HEPATOMA |